Characteristics of the actions by which 5-hydroxytryptamine affects electrical and mechanical activities in rabbit jugular vein graft

British Journal of Pharmacology

Volumn 166, Issue 4, 2012, Pages 1419-1432

  Maekawa, Takashi ^a   Komori, Kimihiro ^a   Kajikuri, Junko ^b   Itoh, Takeo ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

5 HT 1B 1D subtype receptor; 5 HT 2A subtype receptor; 5 HT 7 subtype receptor; 5 hydroxytryptamine; autologous vein graft; endothelium; jugular vein

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; HYDROXYFASUDIL; MYOSIN HEAVY CHAIN; NIFEDIPINE; PROSTAGLANDIN F2 ALPHA; SEROTONIN; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D ANTAGONIST; SEROTONIN 1D RECEPTOR; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CELL DIFFERENTIATION; CONTROLLED STUDY; DEPOLARIZATION; ELECTRIC ACTIVITY; ENZYME ACTIVITY; ENZYME REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JUGULAR VEIN; MALE; MECHANICS; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RABBIT; SMOOTH MUSCLE FIBER MEMBRANE POTENTIAL; WESTERN BLOTTING;

ANIMALS; CAROTID ARTERY, COMMON; DINOPROST; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; JUGULAR VEINS; MALE; MEMBRANE POTENTIALS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOSIN HEAVY CHAINS; NITRIC OXIDE; PROTEIN ISOFORMS; RABBITS; RECEPTORS, SEROTONIN; RHO-ASSOCIATED KINASES; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; TRANSPLANTATION, AUTOLOGOUS; UP-REGULATION; VASCULAR GRAFTING;

EID: 84861306273     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01867.x     Document Type: Article

References (52)

1. Abeles D, Kwei S, Stavrakis G, Zhang Y, Wang ET, García- Cardeña G, (2006). Gene expression changes evoked in a venous segment exposed to arterial flow. J Vasc Surg 44: 863-870.
2. Aikawa M, Sivam PN, Kuro-o M, Kimura K, Nakahara K, Takewaki S, et al,. (1993). Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 73: 1000-1012.
3. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
4. Banno H, Takei Y, Muramatsu T, Komori K, Kadomatsu K, (2006). Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg 44: 633-641.
5. Cocks TM, Angus JA, (1983). Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305: 627-630.
6. Cooley BC, (2004). Murine model of neointimal formation and stenosis in vein grafts. Arterioscler Thromb Vasc Biol 24: 1180-1185.
7. Davies MG, Hagen PO, (1995). Pathophysiology of vein graft failure: a review. Eur J Vasc Endovasc Surg 9: 7-18.
8. Diao Y, Guthrie S, Xia SL, Ouyang X, Zhang L, Xue J, et al,. (2008). Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts. Am J Pathol 172: 839-848.
9. 2B receptors of endothelium-dependent relaxation in rat jugular vein. Br J Pharmacol 114: 400-404.
10. Frieden M, Bény JL, (1995). Effect of 5-hydroxytryptamine on the membrane potential of endothelial and smooth muscle cells in the pig coronary artery. Br J Pharmacol 115: 95-100.
11. Furuyama T, Komori K, Shimokawa H, Matsumoto Y, Uwatoku T, Hirano K, et al,. (2006). Long-term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits. J Vasc Surg 43: 1249-1256.
12. Garland CJ, (1985). Endothelial cells and the electrical and mechanical responses of the rabbit coronary artery to 5-hydroxytryptamine. J Pharmacol Exp Ther 233: 158-162.
13. Garland CJ, (1987). The role of membrane depolarization in the contractile response of the rabbit basilar artery to 5-hydroxytryptamine. J Physiol 392: 333-348.
14. Gaudino M, Prati F, Caradonna E, Trani C, Burzotta F, Schiavoni G, et al,. (2005). Implantation in coronary circulation induces morphofunctional transformation of radial grafts from muscular to elastomuscular. Circulation 112 (9 Suppl.): I208-I211.
15. 2B receptors. Br J Pharmacol 130: 692-698.
16. Glusa E, Roos A, (1996). Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine. Br J Pharmacol 119: 330-334.
17. Grayson KL, Gupta P, (1995). Preliminary characterization of an endothelial 5-HT receptor which mediates relaxation in a preparation of dog isolated vena cava. Br J Pharmacol 116: 409P.
18. 1D subtype. Br J Pharmacol 106: 703-709.
19. Harder DR, Waters A, (1983). Electromechanical coupling in feline basilar artery in response to serotonin. Eur J Pharmacol 93: 95-100.
20. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al,. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46: 157-203.
21. Hu Y, Mayr M, Metzler B, Erdel M, Davison F, Xu Q, (2002). Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ Res 91: e13-e20.
22. Ishida M, Komori K, Yonemitsu Y, Taguchi K, Onohara T, Sugimachi K, (2001). Immunohistochemical phenotypic alterations of rabbit autologous vein grafts implanted under arterial circulation with or without poor distal runoff-implications of vein graft remodeling. Atherosclerosis 154: 345-354.
23. Itoh H, Komori K, Funahashi S, Okadome K, Sugimachi K, (1994). Intimal hyperplasia of experimental autologous vein graft in hyperlipidemic rabbits with poor distal runoff. Atherosclerosis 110: 259-270.
24. Itoh T, Kajikuri J, (2011). Characteristics of the actions by which 5-hydroxytryptamine affects electrical and mechanical activities in rabbit jugular vein. Br J Pharmacol 164: 979-991.
25. Itoh T, Seki N, Suzuki S, Ito S, Kajikuri J, Kuriyama H, (1992). Membrane hyperpolarization inhibits agonist-induced synthesis of inositol 1,4,5-trisphosphate in rabbit mesenteric artery. J Physiol 451: 307-328.
26. Jiang Z, Wu L, Miller BL, Goldman DR, Fernandez CM, Abouhamze ZS, et al,. (2004). A novel vein graft model: adaptation to differential flow environments. Am J Physiol Heart Circ Physiol 286: H240-H245.
27. Kajikuri J, Watanabe Y, Ito Y, Ito R, Yamamoto T, Itoh T, (2009). Characteristic changes in coronary artery at the early hyperglycaemic stage in a rat type 2 diabetes model and the effects of pravastatin. Br J Pharmacol 158: 621-632.
28. Kandabashi T, Shimokawa H, Mukai Y, Matoba T, Kunihiro I, Morikawa K, et al,. (2002). Involvement of Rho-kinase in agonist-induced contractions of arteriosclerotic human arteries. Arterioscler Thromb Vasc Biol 22: 243-248.
29. Kim HS, Aikawa M, Kimura K, Kuro-o M, Nakahara K, Suzuki T, et al,. (1993). Ductus arteriosus. Advanced differentiation of smooth muscle cells demonstrated by myosin heavy chain isoform expression in rabbits. Circulation 88: 1804-1810.
30. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, et al,. (1996). Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248.
31. Kodama A, Komori K, Hattori K, Yamanouchi D, Kajikuri J, Itoh T, (2009a). Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft. J Vasc Surg 49: 1272-1281.
32. Kodama A, Komori K, Kajikuri J, Itoh T, (2009b). Chronic treatment of hydroxytryptamine type 2A receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts. J Vasc Surg 50: 617-625.
33. Komori K, Yamamura S, Ishida M, Matsumoto T, Kuma S, Eguchi D, et al,. (1997). Acceleration of impairment of endothelium-dependent response under poor runoff conditions in canine autogenous vein grafts. Eur J Vasc Endovasc Surg 14: 475-481.
34. Kuro-o M, Nagai R, Nakahara K, Katoh H, Tsai RC, Tsuchimochi H, et al,. (1991). cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J Biol Chem 266: 3768-3773.
35. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, et al,. (1986). Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 314: 1-6.
36. Lopes RD, Hafley GE, Allen KB, Ferguson TB, Peterson ED, Harrington RA, et al,. (2009). Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med 361: 235-244.
37. Makhoul RG, Davis WS, Mikat EM, McCann RL, Hagen PO, (1987). Responsiveness of vein bypass grafts to stimulation with norepinephrine and 5-hydroxytryptamine. J Vasc Surg 6: 32-38.
38. Marcos E, Fadel E, Sanchez O, Humbert M, Dartevelle P, Simonneau G, et al,. (2004). Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res 94: 1263-1270.
39. Motwani JG, Topol EJ, (1998). Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97: 916-931.
40. Muto A, Yi T, Harrison KD, Dávalos A, Fancher TT, Ziegler KR, et al,. (2011). Eph-B4 prevents venous adaptive remodeling in the adult arterial environment. J Exp Med 208: 561-575.
41. Nagai R, Kuro-o M, Babij P, Periasamy M, (1989). Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. J Biol Chem 264: 9734-9737.
42. Okies JE, Page US, Bigelow JC, Krause AH, Salomon NW, (1984). The left internal mammary artery: the graft of choice. Circulation 70 (3 Pt 2): I213-I221.
43. Owens CD, (2010). Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. J Vasc Surg 51: 736-746.
44. Radic ZS, O'Donohoe MK, Schwartz LB, Stein AD, Mikat EM, McCann RL, et al,. (1991). Alterations in serotonergic receptor expression in experimental vein grafts. J Vasc Surg 14: 40-47.
45. 1D receptor subtype. J Pharmacol Exp Ther 252: 387-395.
46. Somlyo AP, Somlyo AV, (1994). Signal transduction and regulation in smooth muscle. Nature 372: 231-236.
47. Takahashi K, Ino T, Ohkubo M, Akimoto K, Kishirou M, (2000). Restenosis after balloon angioplasty of coarctation: relationship with ductus arteriosus. Pediatr Int 42: 658-667.
48. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, et al,. (1997). Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994.
49. 2+ mobilization in rabbit arterial smooth muscle. Br J Pharmacol 117: 1302-1308.
50. Yamanouchi D, Banno H, Nakayama M, Sugimoto M, Fujita H, Kobayashi M, et al,. (2005). Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition. J Vasc Surg 42: 757-764.
51. Zhang L, Freedman NJ, Brian L, Peppel K, (2004). Graft-extrinsic cells predominate in vein graft arterialization. Arterioscler Thromb Vasc Biol 24: 470-476.
52. Zhang WD, Bai HZ, Sawa Y, Yamakawa T, Kadoba K, Taniguchi K, et al,. (1999). Association of smooth muscle cell phenotypic modulation with extracellular matrix alterations during neointima formation in rabbit vein grafts. J Vasc Surg 30: 169-183.